US$ 25.98
retatrutide liver Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of fat #NAFLD in PPL with #obesity #ADA2023 @ADA_DiabetesPro @AmDiabetesAssn #NASH trial coming Retatrutide: Fat Loss, Liver Health
Description
A randomised trial found that patients who adhered to a low-calorie diet while on liraglutide lost significantly more weight than those who did not modify their diet, averaging an additional 3 kg over six months

QR systems

No other single injectable compound does all three
The glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide-1 (GLP-1) are the best-studied and most commonly used incretins
